This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
ETF News and Commentary: Archive
SK Hynix's $720B AI Memory Expansion: Bet on These ETFs to Capture the Boom
by Aparajita Dutta
SK Hynix's $720B memory expansion targets soaring AI demand, while three ETFs offer diversified exposure to the HBM boom.
EWYNegative Net Change IXUSNegative Net Change DRAMNegative Net Change SKHYNegative Net Change
artificial-intelligence computers etfs
Disruptive Technologies ETF (DTEC) Touches New 52-Week High
by Zacks Equity Research
DTEC hits a 52-week high as AI software demand, cybersecurity spending and easing rate expectations fuel tech momentum.
DTECNegative Net Change
etfs
Cybersecurity Demand Fuels CrowdStrike's Earnings Beat: ETFs in Focus
by Yashwardhan Jain
CrowdStrike's earnings beat highlights strong cybersecurity demand. Discover ETFs positioned to benefit from CRWD's growth and the broader sector's momentum.
CRWDNegative Net Change HACKNegative Net Change CIBRNegative Net Change BUGNegative Net Change WCBRNegative Net Change XANegative Net Change
cybersecurity etfs
ETFs to Watch After Revival of Bitcoin
by Zacks Equity Research
Bitcoin reclaims $80K as Treasury liquidity and ETF inflows fuel its 2026 comeback. Can IBIT, FBTC, BITB and ARKB ride the rally?
IBITNegative Net Change FBTCNegative Net Change ARKBNegative Net Change BITBNegative Net Change
bitcoin etfs
ETFs to Buy as NVIDIA Beats on Q2 Earnings, Views 70% Top-Line Growth in FY28
by Aparajita Dutta
NVIDIA beats Q2 estimates and sees 70% fiscal 2028 revenue growth, while NVDA-heavy ETFs offer exposure with less company-specific risk.
NVDANegative Net Change SMHNegative Net Change FTECNegative Net Change IYWNegative Net Change SHOCNegative Net Change AAPLPositive Net Change TSMNegative Net Change
etfs tech-stocks
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
by Aparajita Dutta
FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.
NVSPositive Net Change BIIBNegative Net Change RHHBYNegative Net Change LLYPositive Net Change ABBVPositive Net Change XLVPositive Net Change PPHPositive Net Change IXJPositive Net Change IBRNNegative Net Change
biotechs etfs medical pharmaceuticals
ETF Industry Aflush With Wild Ideas & Launches: Will This Boom Last?
by Sanghamitra Saha
Wall Street is turning wild ideas into ETFs, from NHL teams and Jensen Huang to peptides and AI materials. But can these niche funds attract assets?
GOPNegative Net Change MAGSNegative Net Change NANCNegative Net Change HUMNNegative Net Change BPRONegative Net Change
etfs
NVIDIA Raises the Bar on AI Growth: AI ETFs to Win
by Sanghamitra Saha
NVIDIA's 70% growth outlook reinforces the AI boom, benefiting ETFs targeting generative AI, quantum computing, robotics and next-gen software.
NVDANegative Net Change AISNegative Net Change ROBONegative Net Change AIQNegative Net Change QTUMNegative Net Change CHATNegative Net Change IGPTNegative Net Change
artificial-intelligence etfs
Copper ETF (ICOP) Hits New 52-Week High
by Zacks Equity Research
ICOP just hit a 52-week high and is up about 92% from its low, as copper prices rally on U.S. tariff expectations, AI demand and China stimulus hopes.
ICOPNegative Net Change
etfs
Apple's AI Mac Push Could Spark New Opportunities: ETFs to Win
by Yashwardhan Jain
Apple is taking its Mac lineup deeper into AI. Could the latest upgrades create fresh opportunities for Apple-heavy ETFs?
AAPLPositive Net Change FTECNegative Net Change VGTNegative Net Change MGKNegative Net Change TOPTNegative Net Change GXPTNegative Net Change TRUTNegative Net Change
etfs tech-stocks